ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Avid Bioservices to Manufacture Zynlonta for ADC Therapeutics
May 26, 2021Avid Bioservices Inc., a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing development and manufacturing services to biotechnology and pharmaceutical companies, will serve as ... -
FDA Approves ADC Therapeutics' Zynlonta
May 08, 2021ADC collaborated with CDMO Sterling Pharma Solutions to develop the cancer drug. -
ADC Therapeutics gets USFDA nod for ZYNLONTA to treat relapsed or refractory diffuse large B-cell lymphoma
April 26, 2021First and only CD19-targeted antibody drug conjugate (ADC) as a single-agent treatment for adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
Pharma Sources Insight January 2025
